ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
3,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
4,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
5,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
6,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
6,3,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
6,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
6,5,Procalcitonin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
6,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
7,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
7,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
7,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
8,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
9,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
11,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
11,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
12,1,Chest tube insertion,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
13,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
14,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Blood product transfusion dependent,Disability issues,Lifestyle issues,SocCi,N
15,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,2,Minimal residual disease,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
17,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
17,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
18,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
18,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
19,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
19,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
20,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
20,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
21,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
21,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
21,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
21,4,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
21,5,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
21,6,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
22,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
22,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
22,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
24,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
25,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
26,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
27,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
28,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
29,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
29,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
30,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,Y
31,1,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
32,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
33,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
34,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
35,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
37,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
37,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
38,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
38,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
39,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
39,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
40,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
40,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
40,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
40,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
40,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
41,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
41,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
41,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
42,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
42,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
43,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
46,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
46,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
46,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
47,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
48,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
49,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
50,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
50,3,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
50,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
50,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
50,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
50,7,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
50,8,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
50,9,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
50,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
50,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
50,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
51,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
51,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
52,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
53,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
53,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
54,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
54,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
55,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
56,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
57,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
58,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
59,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
62,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
63,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
64,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
66,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
67,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
68,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
69,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
70,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
71,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
72,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
73,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
74,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
76,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
77,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
78,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
78,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
78,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
78,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
78,5,Physical deconditioning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
78,7,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
79,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,N
79,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
80,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
